Form 144 QUEST DIAGNOSTICS INC For: 13 February
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Quest Diagnostics orporated (DGX)
Assess today's live Quest Diagnostics orporated (DGX) share price, performance and insights using our live NYSE: DGX stock exchange data.
Analyse the historical data and Quest Diagnostics orporated share price performance charts on this page. Our technical summary section provides analysis on Quest Diagnostics share price buy/sell indicators using real-time data (or discuss the Quest Diagnostics (DGX) stock price today with other investors in the Quest Diagnostics NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE DGX share price (ISIN: US74834L1008) to enhance your trading decisions with our free investment tools and resources.
What Is the Quest Diagnostics orporated Share Price Today?
The Quest Diagnostics share price today is 206.87.
What Is the Stock Symbol for Quest Diagnostics orporated
The stock symbol (or 'ticker') for Quest Diagnostics Incorporated is "DGX."
What Stock Exchange Does Quest Diagnostics orporated Trade On?
Quest Diagnostics Incorporated is listed and trades on the NYSE stock exchange.
Is Quest Diagnostics orporated a Good Stock to Buy?
Determining whether Quest Diagnostics Incorporated—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Quest Diagnostics orporated share price performance charts on this page. Our technical summary section provides analysis on Quest Diagnostics share price buy/sell indicators using real-time data (or discuss the Quest Diagnostics (DGX) stock price today with other investors in the Quest Diagnostics NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE DGX share price (ISIN: US74834L1008) to enhance your trading decisions with our free investment tools and resources.
What Is the Quest Diagnostics orporated Share Price Today?
The Quest Diagnostics share price today is 206.87.
What Is the Stock Symbol for Quest Diagnostics orporated
The stock symbol (or 'ticker') for Quest Diagnostics Incorporated is "DGX."
What Stock Exchange Does Quest Diagnostics orporated Trade On?
Quest Diagnostics Incorporated is listed and trades on the NYSE stock exchange.
Is Quest Diagnostics orporated a Good Stock to Buy?
Determining whether Quest Diagnostics Incorporated—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
204.58
209.39
52 wk Range
157.20
213.20
DGX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
204.58209.39
52 wk Range
157.20213.20
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.66%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.66%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DGX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
216.44
Upside
+4.62%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
- Quest Diag receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Quest Diag receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Quest Diag receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Quest Diag receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Form 144 QUEST DIAGNOSTICS INC For: 13 February
- Investing.com
- Quest Diag receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Quest Diag receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Quest Diag receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Quest Diag receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Quest Diagnostics Company Profile
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Quest Diagnostics Incorporated Earnings Call Summary for Q4/2025
- Quest Diagnostics exceeded Q4 2025 expectations with EPS of $2.42 and revenue of $2.81 billion (up 7.1% YoY), driving a 1.44% pre-market stock increase to $194.
- Strong performance was fueled by an 8.5% increase in total volume, with full-year organic revenue growth reaching 6.4% and cash from operations totaling $1.89 billion.
- The company issued 2026 guidance projecting revenue of $11.7-11.82 billion (6-7.1% growth) and adjusted EPS of $10.50-10.70, indicating continued momentum.
- CEO Jim Davis emphasized focus on preventative health and expanding consumer access, while CFO Sam Samad highlighted growing success of QuestHealth.com.
- Key challenges include potential impacts from PAMA legislation delays, competitive pressures, economic conditions, supply chain disruptions, and keeping pace with diagnostic innovations.
Last Updated: 10/02/2026, 14:58
Read Full TranscriptCompare DGX to Peers and Sector
Metrics to compare | DGX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDGXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 23.0x | 20.6x | −0.5x | |
PEG Ratio | 1.67 | 0.73 | 0.00 | |
Price/Book | 3.2x | 3.0x | 2.6x | |
Price / LTM Sales | 2.1x | 1.9x | 3.3x | |
Upside (Analyst Target) | 6.3% | 29.6% | 47.0% | |
Fair Value Upside | Unlock | 18.8% | 5.9% | Unlock |
Analyst Ratings
9 Buy
7 Hold
1 Sell
Ratings:
17 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 216.44
(+4.62% Upside)
Earnings
Latest Release
Feb 10, 2026
EPS / Forecast
2.42 / 2.36
Revenue / Forecast
2.81B / 2.75B
People Also Watch
FAQ
What Is the Quest Diagnostics (DGX) Share Price Today?
The live Quest Diagnostics share price today is 206.87
What Stock Exchange Does Quest Diagnostics (DGX) Trade On?
Quest Diagnostics is listed and trades on the New York Stock Exchange.
What Is the Ticker (Stock Symbol) for Quest Diagnostics?
The stock symbol (also called a 'ticker') for Quest Diagnostics is "DGX."
Does Quest Diagnostics Pay Dividends? What’s The Current DGX Dividend Yield?
Yes, DGX Pays Dividends to its Shareholders. The current Quest Diagnostics dividend yield is 1.66%.
What Is the Current Quest Diagnostics Market Cap?
As of today, Quest Diagnostics market capitalisation is 22.76B.
What Is Quest Diagnostics's (DGX) Earnings Per Share (TTM)?
The Quest Diagnostics EPS is currently 8.75 (Trailing Twelve Months).
When Is the Next Quest Diagnostics Earnings Date?
Quest Diagnostics's next earnings report will be released on 28/04/2026.
Is DGX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Quest Diagnostics moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Quest Diagnostics Stock Split?
Quest Diagnostics has split 2 times. (See the DGX stock split history page for full effective split date and price information.)
How Many Employees Does Quest Diagnostics Have?
Quest Diagnostics has 57000 employees.
What is the current trading status of Quest Diagnostics (DGX)?
As of 16 Feb 2026, Quest Diagnostics (DGX) is trading at a price of 206.87, with a previous close of 206.86. The stock has fluctuated within a day range of 204.58 to 209.39, while its 52-week range spans from 157.20 to 213.20.
What Is Quest Diagnostics (DGX) Price Target According to Analysts?
The average 12-month price target for Quest Diagnostics is USD216.44, with a high estimate of USD235 and a low estimate of USD166. 9 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +4.62% Upside potential.
What Is the DGX Premarket Price?
DGX's last pre-market stock price is 210.73. The pre-market share volume is 10.00, and the stock has decreased by 3.87, or 1.87%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.